Login
Goldenwell Biotech Inc logo

Goldenwell Biotech Inc

goldenwellbiotech.com

What Do They Do?

Sells nutraceutical and dietary supplements, including peptide powders and tablets, to individual consumers.

How Do They Make Money?

FY2025 revenue

Who Are Their Customers?

Its supplements are aimed at individual consumers. Se Plus targets middle-aged and elderly people and people who are selenium deficient.

Do Revenues Turn Into Profits?

No. It lost $296.5K in FY2025.

Operating income, FY2025
−206047% of revenue
▼ −8% (Loss) vs FY2024 (−$123.1K, −88560%)
Net income, FY2025
−539038% of revenue
▲ +125% (Loss) vs FY2024 (−$131.5K, −94603%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Revenue
vs $0 in Q2 FY2025
Net income
▲ +22% (Loss)
vs −$30.3K in Q2 FY2025

Shrinking. Revenue fell 100% in 4 years, from $16K in FY2021 to $55 in FY2025, about 76% a year.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support